607 filings
Page 2 of 31
8-K
qvghkf8
5 May 23
Regulation FD Disclosure
4:05pm
8-K
170lnorulehw4 28luy
13 Apr 23
Entry into a Material Definitive Agreement
8:30am
8-K
8c2kbj6do01qb8ee8g
6 Apr 23
Form of Securities Purchase Agreement
8:30am
NT 10-K
hlvxkr3
31 Mar 23
Notice of late annual filing
4:15pm
8-K
oi7 rqkqevl2l
28 Mar 23
RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
8:55am
8-K
r2fw8hl glzmal6
1 Mar 23
ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx’s Entry into a Services Agreement with iNGENu CRO Pty Ltd
8:50am
8-K
iygzkzehq 07m
1 Feb 23
Regulation FD Disclosure
8:45am
8-K
joasjlux jdjb
23 Jan 23
RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
8:45am
8-K
mkeywt
12 Jan 23
RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
9:00am
8-K
hmuq9bh k86n1u0
17 Nov 22
Regulation FD Disclosure
9:00am
NT 10-Q
6dzewdt9ft1whaoi
14 Nov 22
Notice of late quarterly filing
4:17pm
8-K
jkagmrrsx
10 Nov 22
RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4
9:00am
8-K
0ybvc
7 Nov 22
RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
9:00am
8-K
uaxj16 82
13 Sep 22
Regulation FD Disclosure
4:05pm
NT 10-Q
elo3954
15 Aug 22
Notice of late quarterly filing
4:13pm
8-K
nn4jr0bn7dkd
3 Aug 22
Payment Settlement Agreement and Release
4:05pm
8-K
qae9 e51g48q1h7zq
16 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am